View more job listings or post a job
Agios Pharmaceuticals Senior Scientist, DMPK/Clinical Pharmacology
UC Davis - California Animal Health and Food Safety Laboratory System Job Title: Analytical Chemist Payroll Title: Staff Research Associate 3 (Exempt) Salary Range:  $4592.00-$7384.00/Month Appointment Type:  Career - 100%  
Precision for Medicine Scientist - Bioanalytical Assays
Chinook Therapeutics, Inc. DMPK Discovery Lead
Boston Biomedical Inc SR/Clinical Research Scientist - Clinical Development - Oncology 
Applied Molecular Transport (AMT) Research Associate, Pharmacology/Biology
Applied Molecular Transport (AMT) Senior Scientist, Pharmacology/Biology
RAPT Therapeutics Research Associate, DMPK
Jazz Pharmaceuticals Senior Manager, Clinical Pharmacology
Post a job


Biotransformation and Disposition of Larger Molecules: Peptides, Nucleotides, Proteins, mAbs, and ADCs

Speakers: Donglu Zhang (Genentech), Mark Cancilla (Merck), Aiming Yu (UC Davis), Jing Li (Alnylam Pharmaceuticals), Fang Xie (Amgen) , Mei Han (Amgen) , Srikanth Kotapat (Bristol-Myers Squibb), Dian Su (Genentech), Ben Shen (Genentech), Divya Samineni (Genentech)Donglu Zhang (Genentech), Mark Cancilla (Merck), Aiming Yu (UC Davis), Jing Li (Alnylam Pharmaceuticals), Fang Xie (Amgen) , Mei Han (Amgen) , Srikanth Kotapat (Bristol-Myers Squibb), Dian Su (Genentech), Ben Shen (Genentech), Divya Samineni (Genentech)
Organizers: Dian Su (Genentech)
Date: 2019-09-13
Time: 8:45-17:00 Pacific Time
Registration fee (USD): Regular: $195; Academic: $125; For unemployed or students: $30; For major-sponsor rep (incl lunch): $0; For vendor-show rep: $35
Location: SF Bay Area: Foster City Crowne Plaza
Major Sponsor: (1)Almac;(Major Sponsorship - afternoon session still open)
Vendor show vendors registered to date: (10)CMIC, Inc.; Covance; Intertek; MicroConstants; PRIMERA ANALYTICAL SOLUTIONS CORP; Promethera Biosciences; Q2 Solutions; QPS, LLC; Waters Corporation; WuXi AppTec
Registration deadline:2019-09-11  (it will close sooner if the seating cap is reached)

About the Topic

​Biotransformation of small molecules is intensively investigated during drug discovery and development stages. In contrast, biotransformation of larger molecules such as antibodies, proteins, antibody-drug conjugates, peptides and nucleotides has been less emphasized. In the last decade, there have been increasing interests and expertise in understanding of larger molecule biotransformation and disposition. This workshop will cover this topic for diverse therapeutics and provide an opportunity for the community to discuss the technical aspect, role and impact of biotransformation for development of larger molecule therapeutics.

Key topics:

  • Introduction to Disposition and Biotransformations of Larger Molecules 
  • Biotransformation and Trafficking of Peptide Therapeutics
  • Biotransforamtion and biodistribution of Oligonucleotide Therapeutics 
  • Biotransformation of Antibody Therapeutics
  • Biotransformation of Next-generation ADCs
  • Tissue Disposition of Protein and Antibody Therapeutics



8:45  Workshop welcome

8:45-9:30  Donglu Zhang (Genentech): Distribution and Disposition of Larger Molecule Drugs: Local Metabolism and Local Concentration

9:30-10:15  Mark Cancilla (Merck): Developing Peptide Therapeutics By Understanding Their Metabolism And Trafficking

10:15-10:30  Morning Break

10:30-11:15  Aiming Yu (UC Davis): Bioengineered RNAi Prodrug: Production, Biotransformation and Efficacy

11:15-11:50  Jing Li (Alnylam Pharmaceuticals): Understanding the Biotransformation of RNAi Therapeutics Using High Resolution Mass Spectrometry

11:50-12:25  Fang Xie (Amgen): Biotransformation of siRNA Therapeutics

12:25-1:20  Lunch

1:20-2:00  Mei Han (Amgen): Biotransformation Study for Protein and Antibody Therapeutics Using Immunoaffinity Purification Capillary Electrophoresis Mass Spectrometry (IA-CE-MS)

2:00-2:35  Srikanth Kotapat (Bristol-Myers Squibb): The Role of LC-MS in In Vivo Biotransformation Assessment of Therapeutic Proteins

2:35-3:10  Dian Su (Genentech): Advanced Strategies, Technologies and Applications in ADC Biotransformation

3:10-3:25 Afternoon Break

3:25-4:05  Ben Shen (Genentech): Considerations and Approaches in Determining Tissue Disposition of Biotherapeutics and Impact on Drug Development

4:05-4:45  Divya Samineni (Genentech): Impact of PBPK Modeling on Polatuzumab Vedotin Labeling – Waiver for Clinical DDI Studies

4:45-5:15 Panel discussion: all speakers/topics

Workshop ends by 5:15pm

2020-02-11, Development of Drug/Device Combinations
2020-02-24, MS Courses by Dr. Jack Henion: Advanced LC-MS/MS (Day1) & Interpretation of MS/MS CID Spectra (Day2)
2020-03-09, Preclinical Models to Guide Therapeutic Development in Oncology
2020-03-16, Clinical Trials Essentials: An Intensive One-Week Course (register for the full week or half day sessions)
2020-04-10, Development of Multivalent Protein Conjugates as a Strategy to Engineer Drug Pharmacology
2020-04-13, Preclinical and Clinical Development of Cell-based Immunotherapies: Translational PKPD, Safety, Biomarker, CMC, Clinical Pharmacology & Clinical Trials
2020-05-12, Regulated Large Molecule Bioanalysis: Fundamentals, the New FDA Guidance and Beyond
2020-05-22, No More Undruggables: Unconventional Approaches for Drug Discovery and Design - prodrugs, PROTACS, fragment-based design, directed evolution and beyond
2020-06-23, Advances in Immuno-Oncology (A Joint Symposium by PBSS and BioScience Forum)
©Pharmaceutical & BioScience Society, International; Last Modified: 1/24/2020; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

Pacific BioLabs Bay Area CRO with 37 years experience in Methods Development & Validation, Bioanalysis, Toxicology, Immunogenicity, Stability Studies & Microbiology
Simulations Plus Intro & Advanced GastroPlus PBPK PBBM modeling workshops Feb. 24-28 in Redwood City, CA. Register today!
Alturas Analytics, Inc. Expert GLP & non-GLP LC-MS/MS, GC-MS/MS bioanalytical & PK/TK analysis services of small & large molecules in any matrix. Discovery through phase IV.
Hypha Discovery Experts in scalable synthesis & purification of drug metabolites, including CYP, AOX, FMO metabolites as well as O-, N-, acyl glucuronides & sulfates
ReechPharma Bay Area (Newark) company, supporting clients with CUSTOMIZED FORMULATIONS that are soluble, stable, scalable & safer. Preclinical to post-marketing!
Submit a Text Ad